Oncologic Surgery

Oncologic surgery is a key surgical subspecialty within the multidisciplinary oncology care framework. Centered on surgical resection, it focuses on the surgical diagnosis and treatment of various solid tumors and collaborates with radiation oncology and medical oncology to facilitate multidisciplinary team (MDT) coordination, thereby delivering standardized, comprehensive cancer care. The department primarily manages solid malignant neoplasms arising from all body sites, including thyroid, breast, gastrointestinal, pulmonary, hepatobiliary–pancreatic, and soft‑tissue tumors, while also addressing certain high‑risk precancerous lesions. Its scope encompasses radical tumor resections, palliative debulking procedures, emergency surgical management of tumor‑related complications, and prophylactic excision of high‑risk tumor foci. Leveraging minimally invasive techniques such as laparoscopy and thoracoscopy, the department strives to minimize surgical trauma while upholding the principle of curative resection, safeguarding organ function, and enhancing patients’ postoperative quality of life.

After receiving a patient, the department conducts comprehensive imaging and pathological examinations to determine the tumor subtype and stage, and performs multidisciplinary assessments to evaluate surgical feasibility. For patients who are candidates for curative surgery, we adhere to oncologic surgical guidelines to achieve complete resection of the primary lesion and regional lymph nodes. For patients with advanced disease who cannot undergo complete curative resection, we offer debulking or palliative procedures to address acute complications such as bleeding, obstruction, or perforation, thereby alleviating suffering. The department places great emphasis on perioperative management across the entire care continuum; for elderly patients or those with multiple comorbidities, we collaborate with the departments of internal medicine and anesthesiology to conduct thorough preoperative evaluations and manage surgical risks. Postoperatively, based on pathology results, we determine whether adjuvant therapies—such as chemotherapy, targeted therapy, or radiotherapy—are necessary, and we establish long-term follow-up records to monitor the risk of tumor recurrence and metastasis. If a physical examination reveals a solid mass highly suspicious for malignancy, or if a confirmed solid tumor requires surgical evaluation, patients may seek consultation at the Department of Surgical Oncology.